GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FDPS, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
11.3115 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FABP3, FABP4, FDPS, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MET, MIF, PPARA, PTGES |
11.112 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KCNH2, KDR, MAOA, MET, MIF, PPARA, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
11.112 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
8.91958 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
8.91958 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
8.19458 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
8.19458 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MIF, MMP12, MMP2, MMP9, PIM1, PTGES, RELA, SLC6A4, SRC, TERT, XDH |
8.19458 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
8.15172 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
8.13976 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, RELA, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
7.83478 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, RELA, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
7.71417 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.71417 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FDPS, FUT7, GBA2, HSD17B3, MIF, PIM1, PPARA, PTGES, TYR, XDH |
7.14347 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KCNH2, KDR, MMP2, MMP9, RELA, RORC, SLC6A4, SRC, TERT |
7.10954 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
7.06711 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
6.9613 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGES, RELA, SRC, TERT |
6.95133 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, PTPRS, RELA, SRC, TYR |
6.95133 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
6.72043 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
6.68201 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF, PTGES |
6.53471 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HSD11B2, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A2, SLC6A4, SRC, TNKS2, TYR |
6.51467 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.47589 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
6.47589 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC1A1, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
6.38129 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF, PTGES |
6.33287 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, PTPN1, RELA, SRC, XDH |
6.29141 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC |
6.24824 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MIF, MMP2, MMP9, PTPN1, RELA, RORC, SLC6A4, SRC, TERT |
6.18433 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RELA, RORC, SLC6A4, SRC |
6.12292 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
5.92047 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, FDPS, GBA2, HSD17B3, MAOA, TYR |
5.84608 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, AR, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, RELA, SLC6A4, SRC |
5.84214 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
5.7578 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.73294 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FDPS, FUT7, GBA2, MET, MIF, PPARA, PTGES |
5.72211 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
5.69831 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CACNA1C, CDC25B, CDK6, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTPRS, RELA, RORC, SLC6A4, SRC, TERT, TNKS2, TYR |
5.64285 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, MIF, PPARA, PTGES |
5.60708 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, RELA, TERT |
5.58287 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.48708 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
5.29007 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MIF, PTGES |
5.29007 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT, XDH |
5.23778 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
5.2056 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
5.20428 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, F3, GRIK5, GRM5, IGF1R, KCNH2, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
5.17643 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.12236 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF, PTGES |
5.10657 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
5.0957 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PTPN1, RELA, SRC, XDH |
5.05233 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.03727 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CDK6, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2 |
5.02407 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.98853 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, ESRRB, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
4.97592 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, GRM1, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, PTPRS, RELA, SLC1A1, SLC6A4, SRC, TERT, TNKS2, XDH |
4.97592 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.97592 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
4.97592 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
4.97592 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, XDH |
4.96222 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.95524 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KCNH2, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.92361 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
4.9236 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.91602 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
4.88709 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, MMP9, PIM1, PPARA, PTPRS, RELA, RORC, SRC, TYR |
4.88709 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP3K7, MET, MIF, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2 |
4.83574 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
4.83053 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
4.78719 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.78059 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MAP2K1, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TERT, XDH |
4.77699 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4 |
4.76025 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A4 |
4.76025 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.65201 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
4.62542 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT |
4.59577 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
4.56224 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CACNA1C, CDK6, KDR, MIF, SRC, TNKS, TNKS2 |
4.54249 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CDK6, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RELA, RORC, SLC6A4, SRC |
4.53586 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GBA2, MIF, PPARA, PTGES |
4.51776 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
4.46347 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CDK6, CYP19A1, ESR1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, PPARA, PTPN1, PTPRS, RELA, SRC, TERT, XDH |
4.41118 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
4.33055 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MET, MIF, MMP9, PTPN1, RELA, SRC, TERT, TNKS, XDH |
4.3279 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
4.30948 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, KCNH2, MET, SRC, TERT |
4.30601 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KCNH2, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
4.23789 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
4.22673 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.22256 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.21835 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, XDH |
4.09787 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
4.08517 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.06781 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
4.05763 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTPN1, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.94314 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
3.93888 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.93346 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TERT |
3.88743 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, GRM1, GRM3, GRM5, GRM8 |
3.78029 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, RELA, SRC, XDH |
3.74051 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
3.74051 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDK6, CYP19A1, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, PTPRS, RELA, SRC, TERT, XDH |
3.74051 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES, TERT |
3.6946 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.6946 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, CACNA1C, GRIA2, GRIA4, GRIK5, GRM5, KCNH2, KDR, SRC |
3.69076 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC, TERT |
3.68946 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CES1, CYP1A1, CYP1B1, KDR, RELA, SLC6A4, SRC |
3.6761 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.65245 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, RELA, SLC1A1, SRC, TERT |
3.5509 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.53975 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.53963 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FDPS, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
3.52446 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, RELA, SLC6A4, SRC, TERT, XDH |
3.51709 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, RELA, SLC6A4, SRC, TERT, XDH |
3.50017 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.48956 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.48956 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, GBA2, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.47544 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.45515 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1, SRC |
3.4183 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, KCNH2, MET |
3.40718 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TERT, TNKS, XDH |
3.39971 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, GRIK5, GRM5, KCNH2, MAP2K1, MIF, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
3.39654 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, RORC, SLC6A4, SRC |
3.39095 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.36835 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, MIF, SRC, TNKS, TNKS2 |
3.36643 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, FABP3, HSD11B2, KCNH2, KDR, RELA, SLC6A2, SLC6A4, SRC |
3.34622 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.34375 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.31126 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MIF, MMP9, PTPN1, RELA, SRC, TERT |
3.29459 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, PTGES, TYR |
3.27226 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FDPS, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
3.23995 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, MAP2K1, MMP2, MMP9, SLC6A4, SRC |
3.2301 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.22485 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MAP2K1, MET, MIF, PIM1, SRC, TYR |
3.22 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.21898 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
3.21898 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, HSD11B2, RELA, SRC |
3.20864 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.15352 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.15352 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, GRM1, HSD11B2, MMP2, PPARA, RELA, SLC6A4, SRC, TERT, TYR |
3.14585 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.12323 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CES1, CYP19A1, FDPS, HSD17B3, TYR |
3.09017 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TNKS |
3.08804 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.08804 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS |
3.07123 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TERT, TNKS, XDH |
3.07123 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.06956 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, FLT3, GRM5, MIF, PTPN1, SRC |
3.06956 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
3.06344 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
3.06344 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TNKS |
3.05574 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
3.0431 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.03178 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, BCL2, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TERT, TNKS, XDH |
3.00964 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
2.9918 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.98545 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.98545 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CDK6, CYP1B1, FABP3, MAP2K1, PTGES, SLC6A4, TERT, XDH |
2.95326 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, GRM5, MIF, PTPN1, SRC |
2.95326 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, SRC |
2.94568 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.94533 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
2.94331 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SLC6A4, SRC |
2.93948 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, BCL2, CA2, CA7, CACNA1C, GRM5, KCNH2, MIF, MMP9, SLC6A4 |
2.89156 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
2.88431 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.88029 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, PTGES, TYR |
2.86614 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.8541 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, GBA2, MIF, PIM1, PPARA, PTGES, TYR |
2.78153 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.77604 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.77604 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, BCL2, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, RELA, SRC, XDH |
2.77604 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS |
2.76184 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, APP, GRM5, PTPN1 |
2.76184 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.75192 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.74482 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.7446 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGES |
2.72361 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, FDPS, HSD17B3, MIF, PTGES |
2.71169 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, HSD11B2, IGF1R, PPARA, RELA, SRC |
2.70786 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.6971 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.6939 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.6939 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.69093 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.69093 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.67558 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.66954 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC, TYR |
2.66147 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, CDK6, ESR1, FLT3, RELA, RORC, SLC6A4, SRC |
2.6585 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.65208 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.60743 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FDPS, FLT3, PPARA, RORC, SRC |
2.60469 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.59688 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.59289 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.57124 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, KCNH2, KDR, RELA, SRC |
2.57101 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, ESR1, F3, FABP4, KDR, MAP2K1, MET, MIF, MMP12, PPARA, PTPRS, RELA |
2.5554 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PPARA, RORC, SLC6A4, SRC |
2.55308 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, KDR, SRC |
2.5395 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.53425 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, GRM5, PTPN1 |
2.51966 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.51033 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CDC25B, CDK6, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MAP2K1, MET, MIF, MMP2, MMP9, PTPRS, RORC, SRC, TERT |
2.50533 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, ESR1, FLT3, GRM5, IGF1R, MMP2, RELA, SLC6A4, SRC |
2.49656 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, ESR1, IGF1R, KDR, MAP2K1, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.48598 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.47294 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.46511 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.46511 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, PTPRS, RELA, SRC, TERT, XDH |
2.43661 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, PIM1, RELA |
2.42314 |
[BP] GO:0023052 |
None
|
ADORA1, AR, CACNA1C, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, KCNH2, SLC1A1, SLC6A2 |
2.42157 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, BCL2, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.40185 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.39166 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A4 |
2.39166 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, RELA, SLC6A4, SRC, TYR |
2.38337 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.36792 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.36792 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.36792 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.34901 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, GRM1, GRM3, GRM5, GRM8 |
2.33499 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.33076 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.31361 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, F3, FLT3, FUT7, GBA2, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, SRC, TNKS, TNKS2, TYR, XDH |
2.31052 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, MAP2K1, MIF, RELA, TERT |
2.30497 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, KCNH2, MIF, MMP12, SLC6A4, SRC, TERT |
2.30076 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.26792 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SRC, TERT, TNKS, TNKS2 |
2.25468 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SRC, TERT, TNKS, TNKS2 |
2.25072 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MET, MIF, MMP9, PTPN1, RELA, SRC, XDH |
2.22946 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.22235 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, SLC1A1 |
2.21869 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, BCL2, CA2, CDK6, CYP19A1, ESR1, ESRRA, MAP3K7, MIF, MMP12, MMP2, PTPN1, PTPRS, RELA, SRC |
2.21485 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, RELA, SRC, TERT |
2.20969 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, MAP2K1, RELA, TYR |
2.20302 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, KDR, MAP2K1, MIF, PIM1, PPARA, PTPRS, RELA, RORC, SLC6A4, SRC, TERT, TNKS2, XDH |
2.1896 |
[BP] GO:0007154 |
None
|
ADORA1, AR, AXL, BCL2, CACNA1C, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.18268 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HSD11B2, RELA, SLC6A4, SRC, TYR |
2.12419 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.11996 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.11996 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.11996 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, IGF1R, MAP2K1, MAP3K7, MET, MIF, PTPN1, PTPRS, TERT, XDH |
2.11421 |
[BP] GO:0090344 |
None
|
CDK6, MIF, TERT |
2.11421 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.11421 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.11421 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.09686 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
2.09234 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MAP2K1, MET, MMP12, PPARA, PTPN1, RELA, RORC, SRC, TERT, TNKS, TNKS2 |
2.09234 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, GRIK5, MAOA, SLC1A1, SLC6A2, SLC6A4 |
2.09234 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
2.09234 |
[BP] GO:0045934 |
None
|
ADRA2A, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, MMP12, PPARA, RELA, RORC, SRC, TERT, TNKS, TNKS2 |
2.08845 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, PPARA |
2.07016 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.0654 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.05738 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, PPARA, SLC1A1, SLC6A2, SLC6A4 |
2.04471 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.04471 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.03323 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, GRM1, GRM3, GRM5, GRM8 |
2.02551 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, GRM1, GRM5, KCNH2 |
2.019 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.019 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, MAP3K7, MMP12, MMP2, PPARA, PTPN1, PTPRS, RELA, SRC |
2.019 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTPN1, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR |
4.54142 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, ESR1, F3, FLT3, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC, TERT |
4.48318 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTPRS, SLC6A4, SRC |
3.5801 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA4, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTPRS, SLC1A1, SLC6A2, SLC6A4 |
3.31126 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.23995 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, PIM1, PTGES, PTPN1, PTPRS, RELA, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
3.22079 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.06956 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, GBA2, GRIA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTPN1 |
3.00431 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CES1, CES2, CYP19A1, FLT3, GBA2, GRIK5, HSD17B3, KDR, MAP2K1, PTPN1, XDH |
2.89583 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AXL, CA2, CA4, CACNA1C, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC |
2.76184 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.65208 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.65208 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MET, PTGES, PTPN1, PTPRS, SLC1A1, SLC6A2, SLC6A4, SRC, TYR |
2.64304 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GRIA4, GRIK5, GRM1, GRM5, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, RORC, SHBG, SLC1A1, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.64304 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTPRS, SLC1A1, SLC6A2, SLC6A4 |
2.60281 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTPRS, SLC6A2, SLC6A4, SRC |
2.51036 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, CA2, CA4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
2.23799 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CACNA1C, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RELA, RORC, SHBG, SLC1A1, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.19639 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
12.0385 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, F3, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, TYR, XDH |
8.78226 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TYR, XDH |
8.19458 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.6169 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.48026 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC, SHBG |
6.95133 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.02533 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.02533 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
5.99875 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
5.89857 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.5665 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
5.50164 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PPARA, RORC |
5.48708 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
5.41411 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CDK6, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
5.41198 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FDPS, MAP3K7, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TYR, XDH |
5.32581 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FDPS, MAP3K7, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TYR, XDH |
5.11945 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
5.08369 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
5.02407 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.62595 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.53095 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.50061 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC, SHBG |
4.39654 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
3.82302 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
3.81106 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, BCL2, CSNK2A1, ESR1, ESR2, FLT3, GRIK5, IGF1R, KCNH2, KDR, MAP3K7, MET, MIF, MMP9, RELA, SLC6A4, TERT, TYR, XDH |
3.71318 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.63481 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.40194 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.31126 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.22485 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.22212 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.2194 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.06956 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD11B2, HSD17B1, PTGES, SRC, XDH |
3.06202 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.05595 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.84848 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.7446 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.7446 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
2.71792 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.6585 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
2.57485 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.55308 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.53677 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SLC6A4, SRC |
2.49368 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.48961 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2C19, ESR1, ESR2, ESRRB, F3, GRM5, KCNH2, MET, MIF, PPARA, PTPN1, RELA, SLC6A4, SRC, TNKS2 |
2.48509 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.36792 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.36792 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.36792 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
2.34901 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.26792 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.26792 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.22767 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.21175 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
2.20629 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
2.20629 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.12336 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.11996 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.11996 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.11996 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.11996 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TERT |
2.11781 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.11676 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.0177 |